MedPath

Oxybuprocaine

Generic Name
Oxybuprocaine
Brand Names
Altafluor, Fluress
Drug Type
Small Molecule
Chemical Formula
C17H28N2O3
CAS Number
99-43-4
Unique Ingredient Identifier
AXQ0JYM303

Overview

Oxybuprocaine (also known as Benoxinate) is a local anesthetic, which is used especially in ophthalmology and otolaryngology. Oxybuprocaine binds to sodium channels and reversibly stabilizes the neuronal membrane which decreases its permeability to sodium ions.

Background

Oxybuprocaine (also known as Benoxinate) is a local anesthetic, which is used especially in ophthalmology and otolaryngology. Oxybuprocaine binds to sodium channels and reversibly stabilizes the neuronal membrane which decreases its permeability to sodium ions.

Indication

Used to temporarily numb the front surface of the eye so that the eye pressure can be measured or a foreign body removed.

Associated Conditions

No associated conditions information available.

FDA Approved Products

Fluorescein Sodium and Benoxinate Hydrochloride
Manufacturer:Oceanside Pharmaceuticals
Route:OPHTHALMIC
Strength:4.4 mg in 1 mL
Approved: 2020/03/19
NDC:68682-732
Fluorescein Sodium and Benoxinate Hydrochloride
Manufacturer:Bausch & Lomb Americas Inc.
Route:OPHTHALMIC
Strength:4.4 mg in 1 mL
Approved: 2023/03/16
NDC:82260-734
ALTAFLUOR
Manufacturer:Altaire Pharmaceuticals Inc.
Route:OPHTHALMIC
Strength:4 mg in 1 mL
Approved: 2022/12/02
NDC:59390-218
Fluorescein Sodium and Benoxinate Hydrochloride
Manufacturer:Bausch & Lomb Incorporated
Route:OPHTHALMIC
Strength:4.4 mg in 1 mL
Approved: 2022/08/31
NDC:24208-734

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath